Search Results - "Ruiz‐Bañobre, Juan"
-
1
Noninvasive detection of microsatellite instability in patients with endometrial cancer
Published in International journal of cancer (15-05-2023)“…The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial…”
Get full text
Journal Article -
2
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Published in The Journal of pathology (01-02-2024)“…Mismatch repair-deficient (MMRd) colorectal cancers (CRCs) have high mutation burdens, which make these tumours immunogenic and many respond to immune…”
Get full text
Journal Article -
3
Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
Published in Journal of cutaneous pathology (01-05-2022)“…Breakthrough targeted therapies have produced significant improvements in survival for cancer patients, but have a propensity to cause cutaneous immune‐related…”
Get full text
Journal Article -
4
Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
Published in International journal of molecular sciences (25-08-2023)“…Gynaecological serous carcinomas (GSCs) constitute a distinctive entity among female tumours characterised by a very poor prognosis. In addition to late-stage…”
Get full text
Journal Article -
5
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy
Published in Scientific reports (27-04-2022)“…Pan-Immune-Inflammation Value (PIV) has been recently proposed as a new blood-based prognostic biomarker in metastatic colorectal cancer (mCRC). Herein we…”
Get full text
Journal Article -
6
-
7
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application
Published in Journal of experimental & clinical cancer research (20-09-2024)“…There has been a rise in endometrial cancer (EC) incidence leading to increased mortality. To counter this trend, improving the stratification of post-surgery…”
Get full text
Journal Article -
8
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma
Published in Frontiers in immunology (10-04-2024)“…In the advanced renal cell carcinoma (RCC) scenario, there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint…”
Get full text
Journal Article -
9
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer
Published in Frontiers in oncology (07-05-2024)“…Radium-223 dichloride (Ra-223) is recommended as a treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients with symptomatic bone…”
Get full text
Journal Article -
10
Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report
Published in Frontiers in oncology (22-11-2016)“…Papillary renal cell carcinoma (PRCC), which represents around 20% of renal cell carcinomas, is a heterogeneous disease that includes different tumor types…”
Get full text
Journal Article -
11
MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles
Published in iScience (17-03-2023)“…Deficiency in DNA MMR activity results in tumors with a hypermutator phenotype, termed microsatellite instability (MSI). Beyond its utility in Lynch syndrome…”
Get full text
Journal Article -
12
DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Published in Gastroenterology (New York, N.Y. 1943) (01-03-2019)“…In the recent few years, significant efforts have been undertaken for the development of different immunotherapeutic approaches against cancer. In this…”
Get full text
Journal Article -
13
Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation
Published in Carcinogenesis (New York) (13-11-2020)“…Abstract Accumulating evidence supports the fact that the mere presence of mucinous differentiation in colorectal cancer (CRC), rather than its proportion, is…”
Get full text
Journal Article -
14
Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells
Published in European journal of pharmaceutics and biopharmaceutics (01-09-2019)“…[Display omitted] MicroRNAs (miRNAs) play a key role on gene expression regulation contributing to cell homeostasis, and they are highly dysregulated in…”
Get full text
Journal Article -
15
Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature
Published in Lung cancer (Amsterdam, Netherlands) (01-06-2017)“…Highlights • It is the second case of psoriatic arthritis development during nivolumab therapy. • Low psoriatic arthritis activity was achieved without…”
Get full text
Journal Article -
16
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
Published in Clinical epigenetics (09-07-2022)“…Current noninvasive assays have limitations in the early detection of colorectal cancer. We evaluated the clinical utility of promoter methylation of the long…”
Get full text
Journal Article -
17
Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy
Published in Translational lung cancer research (01-12-2019)“…The lung immune prognostic index (LIPI) has been proposed as a new categorical blood-based biomarker to select advanced non-small cell lung cancer (NSCLC)…”
Get full text
Journal Article -
18
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis
Published in Journal of clinical medicine (03-07-2020)“…The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option…”
Get full text
Journal Article -
19
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group
Published in Journal of geriatric oncology (01-04-2021)“…Nivolumab is an anti PD1 immunotherapy drug approved for advanced Non-Small Cell Lung Cancer (NSCLC) patients who previously received at least one prior line…”
Get full text
Journal Article -
20
Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy
Published in Advances in cancer research (2021)“…Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. Despite ongoing efforts aimed at increasing screening for…”
Get full text
Journal Article